BRIEF-Keymed Biosciences Posts FY Revenue Of RMB428.1 Million

Reuters
24 Mar
BRIEF-Keymed Biosciences Posts FY Revenue Of RMB428.1 Million

March 24 (Reuters) - Keymed Biosciences Inc 2162.HK:

  • FY REVENUE RMB 428.1 MILLION

  • FY NET INCOME ATTRIBUTABLE RMB -480.6 MILLION

Further company coverage: 2162.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10